Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTRA: PegIFN alpha-2a + Ribavirin in HIV/HCV Co-infection with Normal ALT
NCT01684787Phase 4Completed
- Start
- Sep 2006
- Primary completion
- May 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in chronic hepatitis C (CHC). Started Sep 2006; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT01684787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01684787.